Home Industries Health Services Robertelli named RI Bio’s new executive director

Robertelli named RI Bio’s new executive director

By

James Bessette

-

07/09/2024

GLENN ROBERTELLI has been appointed as RI Bio's new executive director. / COURTESY RI BIO

PROVIDENCE – Glenn Robertelli, who has more than a quarter century worth of experience working in the technology, medical and consumer products industries, has been named the new executive director of RI Bio, the life sciences nonprofit announced Tuesday. Robertelli succeeds Carol A. Malysz, who has since retired from the organization after leading it for

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

Critical RI business news and analysis updated daily.
1 year of print (26 issues).
Unlimited access to all subscriber only content on our website, on any device.
Free email alerts.
Annual Book of Lists Print Edition.
All special issues produced during subscription term.

Click Here to purchase a paywall bypass link for this article

PBN Branded Content

Rhode Island FC To Offer Local Businesses Top-Notch Networking Opportunities in 2025

The perfect atmosphere for entertaining clients or hosting employees, The Stadium at Tidewater Landing will…

Learn More

LEAVE A REPLY Cancel reply

PROVIDENCE – Glenn Robertelli, who has more than a quarter century worth of experience working in the technology, medical and consumer products industries, has been named the new executive director of RI Bio, the life sciences nonprofit announced Tuesday. Robertelli succeeds Carol A. Malysz, who has since retired from the organization after leading it for seven years. RI Bio says Robertelli, who started his new role July 1, recently served as the co-founder and chief operating officer at Admetsys Corp., based in Boston. There, Robertelli, RI Bio says, had been instrumental in driving the convergence of biosensors, artificial intelligence, patient-specific metabolic modeling and automated drug delivery. The company under Robertelli’s leadership also developed a diagnostics and clinical robotics platform using AI and biosensors to optimize patient outcomes. Now, Robertelli will lead the organization that has grown to become Rhode Island’s life sciences hub, with a trade group of more than 220 members. In a statement, Robertelli says he is excited to lead RI Bio through its next growth phase. “Our industry stands at the forefront of groundbreaking advancements that have the potential to transform lives,” he said. “I am committed to fostering innovation, collaboration and growth within Rhode Island’s life sciences sector, ensuring that we lead in scientific excellence and patient safety while increasing the sector’s economic impact.” RI Bio board Chairperson Jaimy Mauricio said in a statement that Robertelli brings a long track record and vast expertise as a life sciences entrepreneur to RI Bio and the greater Rhode Island life sciences community. The board chose Robertelli because of “his dedication to building high-performing teams and ecosystems and excellent strategic plan for the organization,” Mauricio said. James Bessette is the PBN special projects editor, and also covers the nonprofit and education sectors. You may reach him at Bessette@PBN.com. You may also follow him on Twitter at @James_Bessette.